skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Characterization and Inhibition of 1-Deoxy- d -Xylulose 5-Phosphate Reductoisomerase: A Promising Drug Target in Acinetobacter baumannii and Klebsiella pneumoniae

Journal Article · · ACS Infectious Diseases
ORCiD logo [1]; ORCiD logo [2];  [2];  [3];  [2];  [3]
  1. Department of Chemistry and Biochemistry, George Mason University, Manassas, Virginia 20109, United States of America, Wound Infections Department, Bacterial Diseases Branch, Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Springs, Maryland 20910, United States of America
  2. Department of Chemistry and Biochemistry, George Mason University, Manassas, Virginia 20109, United States of America
  3. Wound Infections Department, Bacterial Diseases Branch, Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Springs, Maryland 20910, United States of America

The ESKAPE pathogens comprise a group of multidrug-resistant bacteria that are the leading cause of nosocomial infections worldwide. The prevalence of antibiotic resistant strains and the relative ease by which bacteria acquire resistance genes highlight the continual need for the development of novel antibiotics against new drug targets. The methylerythritol phosphate (MEP) pathway is an attractive target for the development of new antibiotics. The MEP pathway governs the synthesis of isoprenoids, which are key lipid precursors for vital cell components such as ubiquinone and bacterial hopanoids. Additionally, the MEP pathway is entirely distinct from the corresponding mammalian pathway, the mevalonic acid (MVA) pathway, making the first committed enzyme of the MEP pathway, 1-deoxy-D-xylulose 5-phosphate reductoisomerase (IspC), an attractive target for antibiotic development. To facilitate drug development against two of the ESKAPE pathogens, Acinetobacter baumannii and Klebsiella pneumoniae, we cloned, expressed, purified, and characterized IspC from these two Gram-negative bacteria. Enzyme inhibition assays using IspC from these two pathogens, and compounds fosmidomycin and FR900098, indicate IC50 values ranging from 19.5-45.5 nM. Antimicrobial susceptibility tests with these inhibitors reveal that A. baumannii is susceptible to FR900098, whereas K. pneumoniae is susceptible to both compounds. Finally, to facilitate structure-based drug design of inhibitors targeting A. baumannii IspC, we determined the 2.5 Å crystal structure of IspC from A. baumannii in complex with inhibitor FR900098, and cofactors NADPH and magnesium.

Research Organization:
Oak Ridge Inst. for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE Office of Science (SC); US Army Medical Research and Development Command (USAMRDC); Military Infectious Disease Research Program; National Institutes of Health (NIH)
Grant/Contract Number:
SC0014664; W81XWH-17-C-0066; W0161_15_WR; 5R01AI123433-04; HHSN272201700059C
OSTI ID:
1826845
Alternate ID(s):
OSTI ID: 1904999
Journal Information:
ACS Infectious Diseases, Journal Name: ACS Infectious Diseases Vol. 7 Journal Issue: 11; ISSN 2373-8227
Publisher:
American Chemical SocietyCopyright Statement
Country of Publication:
United States
Language:
English

References (71)

The clinical use of colistin in patients with cystic fibrosis journal January 2001
Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake journal January 2008
GcpE Is Involved in the 2- C -Methyl- d -Erythritol 4-Phosphate Pathway of Isoprenoid Biosynthesis in Escherichia coli journal April 2001
Trauma-related Infections in Battlefield Casualties From Iraq journal January 2007
Copper Resistance of the Emerging Pathogen Acinetobacter baumannii journal October 2016
Insights into Acinetobacter War-Wound Infections, Biofilms, and Control journal January 2010
Lipophilic Prodrugs of FR900098 Are Antimicrobial against Francisella novicida In Vivo and In Vitro and Show GlpT Independent Efficacy journal October 2012
Septic complications of war wounds journal February 1972
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review journal August 2006
Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs journal December 2011
Fosmidomycin, a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis journal October 1998
Structure of 1-deoxy- D -xylulose 5-phosphate reductoisomerase in a quaternary complex with a magnesium ion, NADPH and the antimalarial drug fosmidomycin journal May 2007
A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis journal August 1998
Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289. journal January 1980
Origins and Early Evolution of the Mevalonate Pathway of Isoprenoid Biosynthesis in the Three Domains of Life journal July 2010
Isoprenoid biosynthetic pathways as anti-infective drug targets journal August 2005
1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase (IspC) from Mycobacterium tuberculosis: towards Understanding Mycobacterial Resistance to Fosmidomycin journal December 2005
CTX-M-Type Extended-Spectrum β-Lactamases in Italy: Molecular Epidemiology of an Emerging Countrywide Problem journal August 2006
Isoprenoid biosynthesis in bacterial pathogens journal March 2012
Biosynthesis of terpenes: Studies on 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase journal August 2002
Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation journal May 2019
Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae journal January 2018
A Promising Target for Treatment of Multidrug-Resistant Bacterial Infections journal May 2011
In vitro synergism of FR-31564, a new phosphonic acid antibiotic. journal January 1981
Fosmidomycin Resistance in Adenylate Cyclase Deficient ( cya ) Mutants of Escherichia coli journal January 2003
A family of transketolases that directs isoprenoid biosynthesis via a mevalonate-independent pathway journal March 1998
Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization. journal January 1980
Design, Synthesis, and X-ray Crystallographic Studies of α-Aryl Substituted Fosmidomycin Analogues as Inhibitors of Mycobacterium tuberculosis 1-Deoxy- d -xylulose 5-Phosphate Reductoisomerase journal July 2011
Structural studies on Mycobacterium tuberculosis DXR in complex with the antibiotic FR-900098 journal January 2012
Isoprenoid biosynthesis: The evolution of two ancient and distinct pathways across genomes journal November 2000
Targeting the Methyl Erythritol Phosphate (MEP) Pathway for Novel Antimalarial, Antibacterial and Herbicidal Drug Discovery: Inhibition of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase (DXR) Enzyme journal April 2007
Notes from the Field : Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae — Washoe County, Nevada, 2016 journal January 2017
Synthesis and Evaluation of 1-Deoxy- d -xylulose 5-Phosphate Analogues as Chelation-Based Inhibitors of Methylerythritol Phosphate Synthase journal October 2005
AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments journal May 2014
LytB protein catalyzes the terminal step of the 2- C -methyl- D -erythritol-4-phosphate pathway of isoprenoid biosynthesis journal December 2002
Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system journal December 2003
Structures of Mycobacterium tuberculosis 1-Deoxy-D-xylulose-5-phosphate Reductoisomerase Provide New Insights into Catalysis journal July 2007
E. coli MEP Synthase:  Steady-State Kinetic Analysis and Substrate Binding journal January 2002
Synthesis of novel 1,2,5-oxadiazoles and evaluation of action against Acinetobacter baumannii journal December 2017
The Crystal Structure of E.coli 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase in a Ternary Complex with the Antimalarial Compound Fosmidomycin and NADPH Reveals a Tight-binding Closed Enzyme Conformation journal January 2005
In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent journal June 1981
Treatment of Acinetobacter infections journal March 2010
Colistin resistance in Klebsiella pneumoniae journal July 2014
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens journal January 2016
Evidence of a Role for LytB in the Nonmevalonate Pathway of Isoprenoid Biosynthesis journal October 2000
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs journal September 1999
Polymyxins Revisited journal July 2008
Multidrug-resistant Organisms in Military Wounds from Iraq and Afghanistan journal January 2008
The lytB Gene of Escherichia coli Is Essential and Specifies a Product Needed for Isoprenoid Biosynthesis journal December 2001
The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections journal January 2017
Acinetobacter baumannii: an emerging multidrug-resistant threat journal June 2008
Kinetic Characterization and Phosphoregulation of the Francisella tularensis 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (MEP Synthase) journal December 2009
Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum journal June 2011
Structural Basis of Fosmidomycin Action Revealed by the Complex with 2-C-Methyl-d-erythritol 4-phosphate Synthase (IspC) journal May 2003
Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility journal June 2012
The Complex Relationship between Virulence and Antibiotic Resistance journal January 2017
Studies on the nonmevalonate terpene biosynthetic pathway: Metabolic role of IspH (LytB) protein journal January 2002
Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance journal August 2013
Kinetic and Chemical Mechanism of Mycobacterium tuberculosis 1-Deoxy- d -xylulose-5-phosphate Isomeroreductase journal April 2004
Characterization of 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase, an Enzyme Involved in Isopentenyl Diphosphate Biosynthesis, and Identification of Its Catalytic Amino Acid Residues journal April 2000
A Second Target of the Antimalarial and Antibacterial Agent Fosmidomycin Revealed by Cellular Metabolic Profiling journal May 2011
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances journal January 2008
Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran journal March 2009
Code blue: Acinetobacter baumannii , a nosocomial pathogen with a role in the oral cavity journal September 2014
In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic. journal January 1980
Kinetic Characterization and Allosteric Inhibition of the Yersinia pestis 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (MEP Synthase) journal August 2014
Proteopedia: Rossmann fold: A beta-alpha-beta fold at dinucleotide binding sites: Rossmann Fold in FAD, NAD and NADP Binding Domains journal February 2015
The Bacterial Flora of the Blood Stream in the Korean Battle Casualty journal January 1955
Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options journal February 2015
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions journal October 2012
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens journal November 1983